Claude Speeg‐Schatz
- Ophthalmology top 1%
- Retinal Diseases and Treatments 21
- Glaucoma and retinal disorders 18
- Ocular Infections and Treatments 13
- Ocular Diseases and Behçet’s Syndrome 13
- Intraocular Surgery and Lenses 9
- Parasitology top 2%
-
- Retinal Imaging and Analysis 9
- Virology top 10%
- Epidemiology top 10%
- Ophthalmology and Visual Impairment Studies 9
-
- Ophthalmology and Eye Disorders 11
- Co-authors
- Arnaud SauerTristan BourcierDavid GaucherErmanno CandolfiOdile VillardAlexander W. PfaffMaher SalehJosé‐Alain Sahel
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Claude Speeg‐Schatz
111 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 107
- Ophthalmology 617
- Parasitology 220
- Radiology, Nuclear Medicine and Imaging 327
- Virology 43
- Epidemiology 307
Countries citing papers authored by Claude Speeg‐Schatz
This map shows the geographic impact of Claude Speeg‐Schatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Speeg‐Schatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Speeg‐Schatz more than expected).
Fields of papers citing papers by Claude Speeg‐Schatz
This network shows the impact of papers produced by Claude Speeg‐Schatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Speeg‐Schatz. The network helps show where Claude Speeg‐Schatz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claude Speeg‐Schatz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2020 | 3 | |
| 3 | 2020 | 2 | |
| 4 | 2019 | 2 | |
| 5 | 2018 | 3 | |
| 6 | 2015 | 4 | |
| 7 | Oral azithromycin versus doxycyclin for the treatment of moderate to severe meibomian gland dysfunction (MGD): a randomized prospective non-inferiority study. | 2014 | 3 |
| 8 | ROBOTIC MICROSURGERY IN OPHTALMOLOGY | 2014 | 1 |
| 9 | 2014 | 1 | |
| 10 | 2013 | 108 | |
| 11 | Il-17a As An Effective Target Of Anti-inflammatory And Anti-parasitic Treatment In Toxoplasmic Uveitis | 2012 | 1 |
| 12 | 2012 | 1 | |
| 13 | 2012 | 5 | |
| 14 | 2012 | 40 | |
| 15 | 2011 | 3 | |
| 16 | 2011 | 1 | |
| 17 | 2009 | 14 | |
| 18 | 2005 | 13 | |
| 19 | 2003 | 53 | |
| 20 | 1998 | 22 |
About Claude Speeg‐Schatz
Claude Speeg‐Schatz is a scholar working on Ophthalmology, Parasitology and Radiology, Nuclear Medicine and Imaging, having authored 119 papers that have together received 1.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (21 papers), Glaucoma and retinal disorders (18 papers), Ocular Infections and Treatments (13 papers), Ocular Diseases and Behçet’s Syndrome (13 papers), Ophthalmology and Eye Disorders (11 papers), Ophthalmology and Visual Impairment Studies (9 papers), Intraocular Surgery and Lenses (9 papers) and Retinal Imaging and Analysis (9 papers). The work is most often cited by research in Ophthalmology (617 citations), Parasitology (220 citations) and Radiology, Nuclear Medicine and Imaging (327 citations). Claude Speeg‐Schatz has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Arnaud Sauer, Tristan Bourcier, David Gaucher, Ermanno Candolfi, Odile Villard, Alexander W. Pfaff, Maher Saleh, José‐Alain Sahel, Hélène Dollfus and Gilles Prévost.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.